Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BMP Pharma Trading AGSTU:BMP +2.78%36 Gross Margin % is 0.00% as of Jun. 2026. GuruFocus rates STU:BMP with a GF Score™ of 36/100. The stock has 1 warning sign investors should review. Among 122 Medical Distribution companies, BMP Pharma Trading AG ranks worse than 100% on this metric.
BMP Pharma Trading AG (STU:BMP) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
BMP Pharma Trading AG had a gross margin of N/A% for the quarter that ended in Jun. 2026 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
BMP Pharma Trading AG Gross Margin % Related Terms
BMP Pharma Trading AG Gross Margin % Historical Data
* Premium members only.
The historical data trend for BMP Pharma Trading AG's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:BMP vs MCK, COR, CAH: Gross Margin % Comparison
For the Medical Distribution subindustry, BMP Pharma Trading AG's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BMP Pharma Trading AG Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, BMP Pharma Trading AG's Gross Margin % distribution charts can be found below:
* The bar in red indicates where BMP Pharma Trading AG's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
BMP Pharma Trading AG (STU:BMP) has a Gross Margin % of 0.00% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on BMP Pharma Trading AG and its competitors. According to the industry distribution chart, BMP Pharma Trading AG ranks #122 out of 122 companies in the Medical Distribution industry.
Is BMP Pharma Trading AG's Gross Margin % too high?
BMP Pharma Trading AG's current Gross Margin % is 0.00%. Based on the distribution chart, BMP Pharma Trading AG ranks #122 out of 122 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, BMP Pharma Trading AG has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does BMP Pharma Trading AG's Gross Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, BMP Pharma Trading AG ranks #122 out of 122 companies for Gross Margin %. This places BMP Pharma Trading AG in the lower half of its industry. The industry median Gross Margin % is 15.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 15.03, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on BMP Pharma Trading AG and its competitors. For the Medical Distribution industry, the median Gross Margin % is 15.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BMP Pharma Trading AG's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BMP Pharma Trading AG stock overvalued right now?
BMP Pharma Trading AG (STU:BMP) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. BMP Pharma Trading AG's overall GF Score™ is 36/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For BMP Pharma Trading AG (STU:BMP), the current Gross Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BMP Pharma Trading AG is a German company engaged in trading of pharmaceutical raw materials, food supplement products, and veterinary raw materials. The services offered by the company include development of microbial processes, Transfer of biotechnological processes, Contract production of biotechnologically and biocatalysts and development of chiral syntheses.
36GF Score
Get the complete analysis for STU:BMP
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BMP has been successfully added to your 
